L-377202

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameL-377202
Drug Alias NameL-377202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsRNA synthesis inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Alabama At BirminghamMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsHormone-Resistant Prostate NeoplasmsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A